Singapore markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.49+0.40 (+3.31%)
At close: 4:00PM EDT
12.49 0.00 (0.00%)
After hours: 04:12PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
62,108
227,547
148,364
0
0
Cost of revenue
5,547
2,392
-
-
-
Gross profit
56,561
225,155
-
-
-
Operating expenses
Research development
130,275
146,936
175,611
171,488
147,603
Selling general and administrative
217,763
199,615
65,854
33,097
21,379
Total operating expenses
348,038
346,551
241,465
204,585
168,982
Operating income or loss
-291,477
-121,396
-93,101
-204,585
-168,982
Interest expense
33,128
22,670
8,120
100
198
Total other income/expenses net
89
515
4,056
2,875
2,192
Income before tax
-324,516
-143,551
-97,165
-201,810
-166,988
Income from continuing operations
-324,516
-143,551
-97,165
-201,810
-166,988
Net income
-324,516
-143,551
-97,165
-201,810
-166,988
Net income available to common shareholders
-324,516
-143,551
-97,165
-201,810
-166,988
Basic EPS
-
-5.23
-3.59
-7.54
-6.98
Diluted EPS
-
-5.23
-3.59
-7.54
-6.98
Basic average shares
-
27,474
27,090
26,754
23,933
Diluted average shares
-
27,474
27,090
26,754
23,933
EBITDA
-
-120,334
-88,726
-201,445
-166,532